For what it's worth:

http://www.prnewswire.com/news-releases/new-law-to-accelerate-att-deployment-of-small-cell-technology-and-position-minnesota-for-the-next-generation-of-wireless-broadband-300467840.html

Well then, thank God I got in at .24 while I had a chance.

Good grief ??

Give RGBP a look. Good things about to happen!

NEWS: Regen BioPharma, Inc. Completes Preclinical Experimentation for Its siRNA NR2F6 Checkpoint Inhibitor
Company is Currently Preparing IND for New Cancer Immuno-Therapy Drug


SAN DIEGO, February 24, 2016 /PRNewswire/ --

Regen BioPharma, Inc., (OTCBB: RGBP) and (PINK: RGBP) announced today completion of experiments, in collaboration with Dr. Santosh Kesari, demonstrating immunological mechanisms of its novel NR2F6 gene silencing approach. Subsequent to these experiments, the Company has begun the process of compiling an Investigational New Drug Application (IND) with the FDA for testing of this approach in cancer patients. Dr. Kesari is Director of Neuro-Oncology, Professor of Neurosciences and Chairman of the Department of Translational Neuro-Oncology and Neuro-Therapeutics at the John Wayne Cancer Center.

The experiments revealed that administration of Regen's proprietary gene silencing compounds triggered cells of the immune system to profoundly produce growth factors such as interleukin-17 and interleukin-18. These factors are critical to inducing an anticancer immune response. The company is currently developing a cellular product that involves extraction of a small amount of patient blood, isolating specific immune cells from the blood, gene-silencing the NR2F6 target in the extracted immune cells, and subsequently re-administering the immune cells. The goal is to "reprogram" the immune cells to attack tumors.

"As an oncologist, I have witnessed firsthand the powerful effects of immune stimulatory drugs called checkpoint inhibitors that have recently entered the market. The experiments completed in our collaboration strongly suggest that NR2F6, Regen's drug target, acts as one of the immunological checkpoints. We are excited to partner with Regen in bringing this new means of stimulating the immune system to patients," said Dr. Kesari.

Regen has recently filed two patent applications covering the molecular pathways activated by NR2F6 silencing. These applications cover mechanisms by which interleukin-17 and interleukin-18, which are produced as a result of NR2F6 gene silencing, mediate various anticancer effects.

"One element of our operating strategy is to aggressively file intellectual property as we develop our product pipeline and mature our different assets into the clinic. By generating deep and broad intellectual property we aim to protect the significant valuation of these assets," said Harry M. Lander, Ph.D., MBA, President and Chief Scientific Officer of Regen. "These preclinical experiments form the basis of our Investigational New Drug application with the FDA as well as the associated patent applications," said Harry M. Lander, Ph.D., MBA, President and Chief Scientific Officer of Regen.

"The success of these recent sets of experiments is testimony to the expedience and efficacy in which science and commercial advancement can be achieved when one engages key opinion leaders such as Dr. Kesari whose group has been performing these types of studies for more than a decade," said Dr. David Koos, CEO and Chairman of Regen. "We are pleased in having completed the preclinical efficacy portion of this program and look forward to the next phase of development, which we aim to culminate in clinical trials."

About Regen BioPharma, Inc.

Regen BioPharma Inc. is a publicly traded biotechnology company (OTCBB: RGBP) and (OTC PINK: RGBP). The Company seeks to identify undervalued regenerative medicine applications in the immunotherapy and stem cell space. The Company is focused on rapidly advancing these technologies through pre-clinical and Phase I/ II clinical trials. Currently the Company is centering on gene silencing therapy for treating cancer, telomeres and small molecule therapies, along with developing stem cell treatments for aplastic anemia.

Disclaimer: This news release may contain forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.

Contact:
Regen BioPharma Inc.
David R. Koos, PhD
Chairman & Chief Executive Officer
619-702-1404 Phone
+1-619-330-2328 Fax
http://www.regenbiopharma.com and http://www.regenbiopharmainc.com
david.koos@regenbiopharma.com

Twitter: Regen BioPharma News:
https://twitter.com/KoosRegen

The Dorsee Company
Debra Dorsee
+1-858-229-6082
Debbie@thedorseecompany.com


SOURCE Regen BioPharma Inc.

Give RGBP a look!

NEWS: Regen BioPharma, Inc. Completes Preclinical Experimentation for Its siRNA NR2F6 Checkpoint Inhibitor
Company is Currently Preparing IND for New Cancer Immuno-Therapy Drug


SAN DIEGO, February 24, 2016 /PRNewswire/ --

Regen BioPharma, Inc., (OTCBB: RGBP) and (PINK: RGBP) announced today completion of experiments, in collaboration with Dr. Santosh Kesari, demonstrating immunological mechanisms of its novel NR2F6 gene silencing approach. Subsequent to these experiments, the Company has begun the process of compiling an Investigational New Drug Application (IND) with the FDA for testing of this approach in cancer patients. Dr. Kesari is Director of Neuro-Oncology, Professor of Neurosciences and Chairman of the Department of Translational Neuro-Oncology and Neuro-Therapeutics at the John Wayne Cancer Center.

The experiments revealed that administration of Regen's proprietary gene silencing compounds triggered cells of the immune system to profoundly produce growth factors such as interleukin-17 and interleukin-18. These factors are critical to inducing an anticancer immune response. The company is currently developing a cellular product that involves extraction of a small amount of patient blood, isolating specific immune cells from the blood, gene-silencing the NR2F6 target in the extracted immune cells, and subsequently re-administering the immune cells. The goal is to "reprogram" the immune cells to attack tumors.

"As an oncologist, I have witnessed firsthand the powerful effects of immune stimulatory drugs called checkpoint inhibitors that have recently entered the market. The experiments completed in our collaboration strongly suggest that NR2F6, Regen's drug target, acts as one of the immunological checkpoints. We are excited to partner with Regen in bringing this new means of stimulating the immune system to patients," said Dr. Kesari.

Regen has recently filed two patent applications covering the molecular pathways activated by NR2F6 silencing. These applications cover mechanisms by which interleukin-17 and interleukin-18, which are produced as a result of NR2F6 gene silencing, mediate various anticancer effects.

"One element of our operating strategy is to aggressively file intellectual property as we develop our product pipeline and mature our different assets into the clinic. By generating deep and broad intellectual property we aim to protect the significant valuation of these assets," said Harry M. Lander, Ph.D., MBA, President and Chief Scientific Officer of Regen. "These preclinical experiments form the basis of our Investigational New Drug application with the FDA as well as the associated patent applications," said Harry M. Lander, Ph.D., MBA, President and Chief Scientific Officer of Regen.

"The success of these recent sets of experiments is testimony to the expedience and efficacy in which science and commercial advancement can be achieved when one engages key opinion leaders such as Dr. Kesari whose group has been performing these types of studies for more than a decade," said Dr. David Koos, CEO and Chairman of Regen. "We are pleased in having completed the preclinical efficacy portion of this program and look forward to the next phase of development, which we aim to culminate in clinical trials."

About Regen BioPharma, Inc.

Regen BioPharma Inc. is a publicly traded biotechnology company (OTCBB: RGBP) and (OTC PINK: RGBP). The Company seeks to identify undervalued regenerative medicine applications in the immunotherapy and stem cell space. The Company is focused on rapidly advancing these technologies through pre-clinical and Phase I/ II clinical trials. Currently the Company is centering on gene silencing therapy for treating cancer, telomeres and small molecule therapies, along with developing stem cell treatments for aplastic anemia.

Disclaimer: This news release may contain forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.

Contact:
Regen BioPharma Inc.
David R. Koos, PhD
Chairman & Chief Executive Officer
619-702-1404 Phone
+1-619-330-2328 Fax
http://www.regenbiopharma.com and http://www.regenbiopharmainc.com
david.koos@regenbiopharma.com

Twitter: Regen BioPharma News:
https://twitter.com/KoosRegen

The Dorsee Company
Debra Dorsee
+1-858-229-6082
Debbie@thedorseecompany.com


SOURCE Regen BioPharma Inc.

RGBP MOVING ON UP!

NEWS: Regen BioPharma, Inc. Completes Preclinical Experimentation for Its siRNA NR2F6 Checkpoint Inhibitor
Company is Currently Preparing IND for New Cancer Immuno-Therapy Drug


SAN DIEGO, February 24, 2016 /PRNewswire/ --

Regen BioPharma, Inc., (OTCBB: RGBP) and (PINK: RGBP) announced today completion of experiments, in collaboration with Dr. Santosh Kesari, demonstrating immunological mechanisms of its novel NR2F6 gene silencing approach. Subsequent to these experiments, the Company has begun the process of compiling an Investigational New Drug Application (IND) with the FDA for testing of this approach in cancer patients. Dr. Kesari is Director of Neuro-Oncology, Professor of Neurosciences and Chairman of the Department of Translational Neuro-Oncology and Neuro-Therapeutics at the John Wayne Cancer Center.

The experiments revealed that administration of Regen's proprietary gene silencing compounds triggered cells of the immune system to profoundly produce growth factors such as interleukin-17 and interleukin-18. These factors are critical to inducing an anticancer immune response. The company is currently developing a cellular product that involves extraction of a small amount of patient blood, isolating specific immune cells from the blood, gene-silencing the NR2F6 target in the extracted immune cells, and subsequently re-administering the immune cells. The goal is to "reprogram" the immune cells to attack tumors.

"As an oncologist, I have witnessed firsthand the powerful effects of immune stimulatory drugs called checkpoint inhibitors that have recently entered the market. The experiments completed in our collaboration strongly suggest that NR2F6, Regen's drug target, acts as one of the immunological checkpoints. We are excited to partner with Regen in bringing this new means of stimulating the immune system to patients," said Dr. Kesari.

Regen has recently filed two patent applications covering the molecular pathways activated by NR2F6 silencing. These applications cover mechanisms by which interleukin-17 and interleukin-18, which are produced as a result of NR2F6 gene silencing, mediate various anticancer effects.

"One element of our operating strategy is to aggressively file intellectual property as we develop our product pipeline and mature our different assets into the clinic. By generating deep and broad intellectual property we aim to protect the significant valuation of these assets," said Harry M. Lander, Ph.D., MBA, President and Chief Scientific Officer of Regen. "These preclinical experiments form the basis of our Investigational New Drug application with the FDA as well as the associated patent applications," said Harry M. Lander, Ph.D., MBA, President and Chief Scientific Officer of Regen.

"The success of these recent sets of experiments is testimony to the expedience and efficacy in which science and commercial advancement can be achieved when one engages key opinion leaders such as Dr. Kesari whose group has been performing these types of studies for more than a decade," said Dr. David Koos, CEO and Chairman of Regen. "We are pleased in having completed the preclinical efficacy portion of this program and look forward to the next phase of development, which we aim to culminate in clinical trials."

About Regen BioPharma, Inc.

Regen BioPharma Inc. is a publicly traded biotechnology company (OTCBB: RGBP) and (OTC PINK: RGBP). The Company seeks to identify undervalued regenerative medicine applications in the immunotherapy and stem cell space. The Company is focused on rapidly advancing these technologies through pre-clinical and Phase I/ II clinical trials. Currently the Company is centering on gene silencing therapy for treating cancer, telomeres and small molecule therapies, along with developing stem cell treatments for aplastic anemia.

Disclaimer: This news release may contain forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.

Contact:
Regen BioPharma Inc.
David R. Koos, PhD
Chairman & Chief Executive Officer
619-702-1404 Phone
+1-619-330-2328 Fax
http://www.regenbiopharma.com and http://www.regenbiopharmainc.com
david.koos@regenbiopharma.com

Twitter: Regen BioPharma News:
https://twitter.com/KoosRegen

The Dorsee Company
Debra Dorsee
+1-858-229-6082
Debbie@thedorseecompany.com


SOURCE Regen BioPharma Inc.

What does that mean?

Good news indeed!!!!

Now use some of that to pay down debt or buyback stock!!!!

Give those of us who have been here something to show progress.

Thanks

"Many doubted the shares would trade".

I can't trade mine!!

It's all selling. No one buying!

Great NEWS!!! FDA APPROVAL FOR HEMAEXELLERATE! smile

On December 10, 2015 Regen Biopharma, Inc. (“Regen”) was informed by the United States Food and Drug Administration that Regen has satisfactorily addressed all clinical hold issues related to Regen’s Investigational New Drug Application for HemaXellerate and may initiate a Phase I clinical trial assessing HemaXellerate in patients with drug-refractory aplastic anemia. The Phase I clinical trial is intended to determine safety and potential efficacy of intravenously administered autologous stromal vascular fraction (SVF) cells in patients with severe, immune suppressive refractory aplastic anemia with the primary endpoints of safety and feasibility and secondary endpoints of efficacy as determined by patients having complete response, partial response or relapse.

HemaXellerate (a therapy under development by Regen) is a patient-specific composition of cells that have been demonstrated to repair damaged bone marrow and stimulate production of blood cells based on previous animal studies.

Great NEWS!!! FDA APPROVAL FOR HEMAEXELLERATE! smile

On December 10, 2015 Regen Biopharma, Inc. (“Regen”) was informed by the United States Food and Drug Administration that Regen has satisfactorily addressed all clinical hold issues related to Regen’s Investigational New Drug Application for HemaXellerate and may initiate a Phase I clinical trial assessing HemaXellerate in patients with drug-refractory aplastic anemia. The Phase I clinical trial is intended to determine safety and potential efficacy of intravenously administered autologous stromal vascular fraction (SVF) cells in patients with severe, immune suppressive refractory aplastic anemia with the primary endpoints of safety and feasibility and secondary endpoints of efficacy as determined by patients having complete response, partial response or relapse.

HemaXellerate (a therapy under development by Regen) is a patient-specific composition of cells that have been demonstrated to repair damaged bone marrow and stimulate production of blood cells based on previous animal studies.

Put this on your radar!!


NEWS Recap form 2nd qtr 10q, heading in the right direction back to huge profits & success; 4 year old company with huge potential.

$LTNC Reports Second Quarter 2015 Financial Results:
Gross Profit Surges 26% Year over Year

Atlanta, GA, United States, via NZINET CORP., 08/18/2015 - - Labor SMART, Inc. (OTCQB: LTNC) (the "Company"), a leader in providing on-demand blue collar staffing primarily in the southeastern United States, today announced it has filed its 10Q for the quarter ending June 26, 2015.

Second Quarter 2015 Highlights:

-Revenue of $6.37 million

-Gross Profit Margins improved to 27.12% vs. 21.21% a year ago

-Record Gross Profit of $1.727 million

-Net Loss reduced by 39.5% to $564k vs. 933k a year ago

"Our results from the second quarter of 2015 illustrate the fantastic progress being made. Last year's decision to shed a sizeable book of business had minimal impact on year over year revenues as we replaced low margin, high risk business with more profitable customer relationships. Despite the $68k year over year decline in top line revenue, the Company's gross profit surged to record levels," said Ryan Schadel, President and CEO of Labor SMART. "In addition to achieving record gross margins, we also reduced our net loss substantially. Year over year net losses are expected to shrink further in the coming quarters and Labor SMART will continue to pursue smart growth opportunities that we believe will drive profitability and position the Company to provide the best experience to our customers across multiple geographies."

Over the last week, the Company has received several inquiries from shareholders and is providing the following answers to those questions:

Q: You've stated before that 100 offices nationwide was your goal, but you've recently sold 5 locations. Has the goal changed?

A: The goal has not changed but the plan has evolved. The major contributor to this evolution was becoming substantially self-insured last year. This changed our financial model drastically, making acquisitions more appealing than organic expansion. Acquisitions do not impact the Company's financial statements in the same way that organic expansion does.

Q: Is the note that Command Center, Inc. bought in default?

A: The Company believes that prior to the sale of the note to Command Center, Inc., the terms of the note were amended by the prior note holder to allow the note to be repaid in monthly installments. The Company provided documentation to the new note holder that, it believes, substantiates the amendment. Additional details regarding this note and the Company's legal action against Command Center, Inc. are included in our recently filed 10Q.

Q: Payroll taxes payable appears to have gone up in the new 10Q. What happened?

A: Early in 2015 the Company created several subsidiaries. Operations were strategically placed into these subsidiaries in preparation for state income tax management strategies on future profits. These subsidiaries were quarterly schedule tax depositors, whereas the parent company is a semi-weekly depositor. The increase in payroll taxes payable from Q1 2015 to Q2 2015 is driven by the change in the required deposit schedule. All taxes accrued during Q2 2015 were paid subsequent to the calendar quarter closing as required.

Q: I see there is a new convertible note agreement on June 1, 2015. I thought we were done with those?

A: The note from June 1, 2015 was part of an extension of a prior note entered into on August 8, 2014. Half of the prior note was refinanced at no material cost to the Company and the maturity date was extended into 2016 at the Company's request.

Q: Is the Company planning to do a reverse split soon?

A: No.

About Labor SMART, Inc.

Labor SMART, Inc. provides On-Demand temporary labor to a variety of industries. The Company's clients range from small businesses to Fortune 100 companies. Labor SMART was founded to provide reliable, dependable and flexible resources for on-demand personnel to small and large businesses in areas that include construction, manufacturing, hospitality, event-staffing, restoration, warehousing, retailing, disaster relief and cleanup, demolition and landscaping. Labor SMART believes it can make a positive contribution each and every day for the benefit of its clients and temporary employees. The Company's mission is to be the provider of choice to its growing portfolio of customers with a service-focused approach that enables Labor SMART to be seen as a resource and partner to its clients.

Safe Harbor Statement

This release contains statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of Labor SMART, Inc., its directors or its officers with respect to, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; (iii) growth strategy and operating strategy. The words "may", "would", "will", "expect", "estimate", "can", "believe", "potential", and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond Labor SMART, Inc.'s ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. More information about the potential factors that could affect the business and financial results is and will be included in Labor SMART, Inc.'s filings with the U.S. Securities and Exchange Commission.

Link back to original article on NuziNet.com

Link back to Labor SMART, Inc. on NuziNet.com

Contact Information

Contact:

Labor SMART, Inc.

shareholderrelations@laborsmart.com
Replies:
$$$$LTNC$$$$$ BIG GAINS COMING IMO!!!!
Prime-Time on 10/29/2015 5:24:58 PM
STICKY THIS MOD.
Prime-Time on 10/29/2015 5:29:40 PM


Report TOS

Put this on your radar!


NEWS Recap form 2nd qtr 10q, heading in the right direction back to huge profits & success; 4 year old company with huge potential.

$LTNC Reports Second Quarter 2015 Financial Results:
Gross Profit Surges 26% Year over Year

Atlanta, GA, United States, via NZINET CORP., 08/18/2015 - - Labor SMART, Inc. (OTCQB: LTNC) (the "Company"), a leader in providing on-demand blue collar staffing primarily in the southeastern United States, today announced it has filed its 10Q for the quarter ending June 26, 2015.

Second Quarter 2015 Highlights:

-Revenue of $6.37 million

-Gross Profit Margins improved to 27.12% vs. 21.21% a year ago

-Record Gross Profit of $1.727 million

-Net Loss reduced by 39.5% to $564k vs. 933k a year ago

"Our results from the second quarter of 2015 illustrate the fantastic progress being made. Last year's decision to shed a sizeable book of business had minimal impact on year over year revenues as we replaced low margin, high risk business with more profitable customer relationships. Despite the $68k year over year decline in top line revenue, the Company's gross profit surged to record levels," said Ryan Schadel, President and CEO of Labor SMART. "In addition to achieving record gross margins, we also reduced our net loss substantially. Year over year net losses are expected to shrink further in the coming quarters and Labor SMART will continue to pursue smart growth opportunities that we believe will drive profitability and position the Company to provide the best experience to our customers across multiple geographies."

Over the last week, the Company has received several inquiries from shareholders and is providing the following answers to those questions:

Q: You've stated before that 100 offices nationwide was your goal, but you've recently sold 5 locations. Has the goal changed?

A: The goal has not changed but the plan has evolved. The major contributor to this evolution was becoming substantially self-insured last year. This changed our financial model drastically, making acquisitions more appealing than organic expansion. Acquisitions do not impact the Company's financial statements in the same way that organic expansion does.

Q: Is the note that Command Center, Inc. bought in default?

A: The Company believes that prior to the sale of the note to Command Center, Inc., the terms of the note were amended by the prior note holder to allow the note to be repaid in monthly installments. The Company provided documentation to the new note holder that, it believes, substantiates the amendment. Additional details regarding this note and the Company's legal action against Command Center, Inc. are included in our recently filed 10Q.

Q: Payroll taxes payable appears to have gone up in the new 10Q. What happened?

A: Early in 2015 the Company created several subsidiaries. Operations were strategically placed into these subsidiaries in preparation for state income tax management strategies on future profits. These subsidiaries were quarterly schedule tax depositors, whereas the parent company is a semi-weekly depositor. The increase in payroll taxes payable from Q1 2015 to Q2 2015 is driven by the change in the required deposit schedule. All taxes accrued during Q2 2015 were paid subsequent to the calendar quarter closing as required.

Q: I see there is a new convertible note agreement on June 1, 2015. I thought we were done with those?

A: The note from June 1, 2015 was part of an extension of a prior note entered into on August 8, 2014. Half of the prior note was refinanced at no material cost to the Company and the maturity date was extended into 2016 at the Company's request.

Q: Is the Company planning to do a reverse split soon?

A: No.

About Labor SMART, Inc.

Labor SMART, Inc. provides On-Demand temporary labor to a variety of industries. The Company's clients range from small businesses to Fortune 100 companies. Labor SMART was founded to provide reliable, dependable and flexible resources for on-demand personnel to small and large businesses in areas that include construction, manufacturing, hospitality, event-staffing, restoration, warehousing, retailing, disaster relief and cleanup, demolition and landscaping. Labor SMART believes it can make a positive contribution each and every day for the benefit of its clients and temporary employees. The Company's mission is to be the provider of choice to its growing portfolio of customers with a service-focused approach that enables Labor SMART to be seen as a resource and partner to its clients.

Safe Harbor Statement

This release contains statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of Labor SMART, Inc., its directors or its officers with respect to, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; (iii) growth strategy and operating strategy. The words "may", "would", "will", "expect", "estimate", "can", "believe", "potential", and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond Labor SMART, Inc.'s ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. More information about the potential factors that could affect the business and financial results is and will be included in Labor SMART, Inc.'s filings with the U.S. Securities and Exchange Commission.

Link back to original article on NuziNet.com

Link back to Labor SMART, Inc. on NuziNet.com

Contact Information

Contact:

Labor SMART, Inc.

shareholderrelations@laborsmart.com
Replies:
$$$$LTNC$$$$$ BIG GAINS COMING IMO!!!!
Prime-Time on 10/29/2015 5:24:58 PM
STICKY THIS MOD.
Prime-Time on 10/29/2015 5:29:40 PM


Report TOS

LTNC NEWS:


NEWS Recap form 2nd qtr 10q, heading in the right direction back to huge profits & success; 4 year old company with huge potential.

$LTNC Reports Second Quarter 2015 Financial Results:
Gross Profit Surges 26% Year over Year

Atlanta, GA, United States, via NZINET CORP., 08/18/2015 - - Labor SMART, Inc. (OTCQB: LTNC) (the "Company"), a leader in providing on-demand blue collar staffing primarily in the southeastern United States, today announced it has filed its 10Q for the quarter ending June 26, 2015.

Second Quarter 2015 Highlights:

-Revenue of $6.37 million

-Gross Profit Margins improved to 27.12% vs. 21.21% a year ago

-Record Gross Profit of $1.727 million

-Net Loss reduced by 39.5% to $564k vs. 933k a year ago

"Our results from the second quarter of 2015 illustrate the fantastic progress being made. Last year's decision to shed a sizeable book of business had minimal impact on year over year revenues as we replaced low margin, high risk business with more profitable customer relationships. Despite the $68k year over year decline in top line revenue, the Company's gross profit surged to record levels," said Ryan Schadel, President and CEO of Labor SMART. "In addition to achieving record gross margins, we also reduced our net loss substantially. Year over year net losses are expected to shrink further in the coming quarters and Labor SMART will continue to pursue smart growth opportunities that we believe will drive profitability and position the Company to provide the best experience to our customers across multiple geographies."

Over the last week, the Company has received several inquiries from shareholders and is providing the following answers to those questions:

Q: You've stated before that 100 offices nationwide was your goal, but you've recently sold 5 locations. Has the goal changed?

A: The goal has not changed but the plan has evolved. The major contributor to this evolution was becoming substantially self-insured last year. This changed our financial model drastically, making acquisitions more appealing than organic expansion. Acquisitions do not impact the Company's financial statements in the same way that organic expansion does.

Q: Is the note that Command Center, Inc. bought in default?

A: The Company believes that prior to the sale of the note to Command Center, Inc., the terms of the note were amended by the prior note holder to allow the note to be repaid in monthly installments. The Company provided documentation to the new note holder that, it believes, substantiates the amendment. Additional details regarding this note and the Company's legal action against Command Center, Inc. are included in our recently filed 10Q.

Q: Payroll taxes payable appears to have gone up in the new 10Q. What happened?

A: Early in 2015 the Company created several subsidiaries. Operations were strategically placed into these subsidiaries in preparation for state income tax management strategies on future profits. These subsidiaries were quarterly schedule tax depositors, whereas the parent company is a semi-weekly depositor. The increase in payroll taxes payable from Q1 2015 to Q2 2015 is driven by the change in the required deposit schedule. All taxes accrued during Q2 2015 were paid subsequent to the calendar quarter closing as required.

Q: I see there is a new convertible note agreement on June 1, 2015. I thought we were done with those?

A: The note from June 1, 2015 was part of an extension of a prior note entered into on August 8, 2014. Half of the prior note was refinanced at no material cost to the Company and the maturity date was extended into 2016 at the Company's request.

Q: Is the Company planning to do a reverse split soon?

A: No.

About Labor SMART, Inc.

Labor SMART, Inc. provides On-Demand temporary labor to a variety of industries. The Company's clients range from small businesses to Fortune 100 companies. Labor SMART was founded to provide reliable, dependable and flexible resources for on-demand personnel to small and large businesses in areas that include construction, manufacturing, hospitality, event-staffing, restoration, warehousing, retailing, disaster relief and cleanup, demolition and landscaping. Labor SMART believes it can make a positive contribution each and every day for the benefit of its clients and temporary employees. The Company's mission is to be the provider of choice to its growing portfolio of customers with a service-focused approach that enables Labor SMART to be seen as a resource and partner to its clients.

Safe Harbor Statement

This release contains statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of Labor SMART, Inc., its directors or its officers with respect to, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; (iii) growth strategy and operating strategy. The words "may", "would", "will", "expect", "estimate", "can", "believe", "potential", and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond Labor SMART, Inc.'s ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. More information about the potential factors that could affect the business and financial results is and will be included in Labor SMART, Inc.'s filings with the U.S. Securities and Exchange Commission.

Link back to original article on NuziNet.com

Link back to Labor SMART, Inc. on NuziNet.com

Contact Information

Contact:

Labor SMART, Inc.

shareholderrelations@laborsmart.com
Replies:
$$$$LTNC$$$$$ BIG GAINS COMING IMO!!!!
Prime-Time on 10/29/2015 5:24:58 PM
STICKY THIS MOD.
Prime-Time on 10/29/2015 5:29:40 PM


Report TOS

Who is hiding the ask, Houdini? Come on don't look for something that is not there.

Holy cow!! Those 400,000 shares bought, were sold by me. I didn't remember even putting those out there. Guess I recouped some of my investment.

What's "interesting" on the site? I don't get it.

I'll buy them when this gets to $1.00.

LOOKING GOOD???!!! Are looking at the same numbers?

You are correct. However, I meant just doing business with this guy and his company is a red flag. Sorry I didn't make that clearer in my first message.

He just did. He let Curt Kramer through the doors. Google Mr. Kramer. It's not good.

Oh no!! Not the old "phony email exchange with CEO" trick. I've seen it played out on other boards. Never works, with even half-informed investors.

GD ENTERTAINMENT & TECHNOLOGY, INC. (GDET) and WOWIO Announce Stock Swap and Joint Venture; Eyes Korean Market for eBook Cont...

Source: InvestorsHub NewsWire








GD ENTERTAINMENT & TECHNOLOGY, INC. (GDET) and WOWIO Announce Stock Swap and Joint Venture; Eyes Korean Market for eBook Content Distribution and English Language Learning



AGOURA, CA -- September 23, 2015 -- InvestorsHub NewsWire -- GD Entertainment & Technology, Inc. (OTC Markets: GDET), today announced that it has signed a definitive Joint Venture Agreement with WOWIO, Inc. (OTC Markets: WWIO) to join forces for the mutual development and exploitation of the WOWIO eBook platform in Korea and other Asian markets. In addition, GDET will seek to distribute WOWIO comic books and graphic novels in Korea in both print and digital form. The WOWIO platform allows for the insertion and tracking of targeted ads directly into the eBook, while providing a methodology for enhancing English language learning for the Korean market. A key part of this joint venture is a preferred stock swap between the two firms, signaling to the markets a deepened and long term commitment to their mutual growth and success.



We are excited about our relationship with GDET and believe that the two companies have tremendous synergies, said Brian Altounian, WOWIOs Chairman. We believe that shareholders from both our companies will benefit in the long term from our growing partnership.



The Korean market provides not only an untapped and growing market for the unique WOWIO platform, but also a way for WOWIO to distribute its proprietary intellectual properties, explained Dong Chung, CEO of GDET. In addition, our technology partners in Korea will enhance the patented WOWIO system to make it more mobile friendly and provide a way for Koreans to learn English in an engaging manner.



Lawrence Bracco, President/COO of GDET stated, The WOWIO platform and content provides us with a way to generate revenues in the first quarter of 2016. We plan on introducing the WOWIO comic/graphic novel library to the Korean market as a way to supplement their English learning in a way thats fun and engaging.



This joint venture with GDET, the first in a series of transactions we hope to accomplish in our new business plan, provides us with a very specific pathway to complete our technology platform, generate revenues and improve our balance sheet through the acquisition of GDET stock, said Robert Estareja, WOWIOs CEO, We are very pleased with the GDET team and vision, and look forward to deepening our relationship with them.



This joint venture also allows for the global cross-licensing of each others content and technology, and paves the way for the potential of an even broader relationship.



About GD Entertainment & Technology, Inc.:

GDET specializes in the development, production and exploitation of media and technologies worldwide. GDET and its management have created, produced, and/or distributed a variety of family-friendly content, including: Conan the Barbarian animated DVD, animated Voyages of Young Dr. Doolittle and Adventures of Odyssey and the acclaimed graphic novel series, The Almighty Bible, an ebook & print version of the Bible for teenagers. GDET principals have over 80 years of combined experience in producing and distributing media, consulting to and licensing major intellectual properties globally, including Warner Brothers, Marvel/Disney, and Mommy & Me. GDET has several projects in development including an animated feature film, a live stage show and an adaptation of a successful juvenile book series for digital video and mobile games. Its acclaimed graphic novel, The Son, is now being distributed in North America and Europe.



About WOWIO



WOWIO, Inc., (OTCBB: WWIO) is a digital media and technology development company with a patented process and a proprietary mobile ad-delivery platform that will disrupt the eBook distribution landscape by exploiting a previously untapped marketplace: ad-supported eBooks. Wowio has built and acquired a number of digital media technologies, platforms and distribution outlets and is focusing its efforts on opportunities to create and monetize ancillary content product lines beyond eBooks and other forms of digital media. To learn more about WOWIO, please visit our corporate website at http://www.studiowdigital.com.



Safe Harbor Statement



Information in this document constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "estimate," "project," "intend," "expect," "should," "believe," and similar expressions are intended to identify forward-looking statements. These statements involve, and are subject to known and unknown risks, which could cause GDET actual results, performance (financial or operating) or achievements to differ from the future results, performance or achievements expressed or implied by such forward-looking statements. The risks, uncertainties and other factors are more fully discussed in GDET filings and Disclosures. All forward-looking statements attributable to GDET herein are expressly qualified in their entirety by the above-mentioned cautionary statement. GD Entertainment & Technology, Inc. disclaims any obligation to update forward-looking statements contained herein, except as may be required by law.



Contact:

Lawrence Bracco

Tel: 805-208-3171 larrybracco@gdetinc.com

Maybe one of their temps are running the ihub website!?

WWIO news, all this and a new CEO:

GD ENTERTAINMENT & TECHNOLOGY, INC. (GDET) and WOWIO Announce Stock Swap and Joint Venture; Eyes Korean Market for eBook Cont...

Source: InvestorsHub NewsWire








GD ENTERTAINMENT & TECHNOLOGY, INC. (GDET) and WOWIO Announce Stock Swap and Joint Venture; Eyes Korean Market for eBook Content Distribution and English Language Learning



AGOURA, CA -- September 23, 2015 -- InvestorsHub NewsWire -- GD Entertainment & Technology, Inc. (OTC Markets: GDET), today announced that it has signed a definitive Joint Venture Agreement with WOWIO, Inc. (OTC Markets: WWIO) to join forces for the mutual development and exploitation of the WOWIO eBook platform in Korea and other Asian markets. In addition, GDET will seek to distribute WOWIO comic books and graphic novels in Korea in both print and digital form. The WOWIO platform allows for the insertion and tracking of targeted ads directly into the eBook, while providing a methodology for enhancing English language learning for the Korean market. A key part of this joint venture is a preferred stock swap between the two firms, signaling to the markets a deepened and long term commitment to their mutual growth and success.



We are excited about our relationship with GDET and believe that the two companies have tremendous synergies, said Brian Altounian, WOWIOs Chairman. We believe that shareholders from both our companies will benefit in the long term from our growing partnership.



The Korean market provides not only an untapped and growing market for the unique WOWIO platform, but also a way for WOWIO to distribute its proprietary intellectual properties, explained Dong Chung, CEO of GDET. In addition, our technology partners in Korea will enhance the patented WOWIO system to make it more mobile friendly and provide a way for Koreans to learn English in an engaging manner.



Lawrence Bracco, President/COO of GDET stated, The WOWIO platform and content provides us with a way to generate revenues in the first quarter of 2016. We plan on introducing the WOWIO comic/graphic novel library to the Korean market as a way to supplement their English learning in a way thats fun and engaging.



This joint venture with GDET, the first in a series of transactions we hope to accomplish in our new business plan, provides us with a very specific pathway to complete our technology platform, generate revenues and improve our balance sheet through the acquisition of GDET stock, said Robert Estareja, WOWIOs CEO, We are very pleased with the GDET team and vision, and look forward to deepening our relationship with them.



This joint venture also allows for the global cross-licensing of each others content and technology, and paves the way for the potential of an even broader relationship.



About GD Entertainment & Technology, Inc.:

GDET specializes in the development, production and exploitation of media and technologies worldwide. GDET and its management have created, produced, and/or distributed a variety of family-friendly content, including: Conan the Barbarian animated DVD, animated Voyages of Young Dr. Doolittle and Adventures of Odyssey and the acclaimed graphic novel series, The Almighty Bible, an ebook & print version of the Bible for teenagers. GDET principals have over 80 years of combined experience in producing and distributing media, consulting to and licensing major intellectual properties globally, including Warner Brothers, Marvel/Disney, and Mommy & Me. GDET has several projects in development including an animated feature film, a live stage show and an adaptation of a successful juvenile book series for digital video and mobile games. Its acclaimed graphic novel, The Son, is now being distributed in North America and Europe.



About WOWIO



WOWIO, Inc., (OTCBB: WWIO) is a digital media and technology development company with a patented process and a proprietary mobile ad-delivery platform that will disrupt the eBook distribution landscape by exploiting a previously untapped marketplace: ad-supported eBooks. Wowio has built and acquired a number of digital media technologies, platforms and distribution outlets and is focusing its efforts on opportunities to create and monetize ancillary content product lines beyond eBooks and other forms of digital media. To learn more about WOWIO, please visit our corporate website at http://www.studiowdigital.com.



Safe Harbor Statement



Information in this document constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "estimate," "project," "intend," "expect," "should," "believe," and similar expressions are intended to identify forward-looking statements. These statements involve, and are subject to known and unknown risks, which could cause GDET actual results, performance (financial or operating) or achievements to differ from the future results, performance or achievements expressed or implied by such forward-looking statements. The risks, uncertainties and other factors are more fully discussed in GDET filings and Disclosures. All forward-looking statements attributable to GDET herein are expressly qualified in their entirety by the above-mentioned cautionary statement. GD Entertainment & Technology, Inc. disclaims any obligation to update forward-looking statements contained herein, except as may be required by law.



Contact:

Lawrence Bracco

Tel: 805-208-3171 larrybracco@gdetinc.com

GD ENTERTAINMENT & TECHNOLOGY, INC. (GDET) and WOWIO Announce Stock Swap and Joint Venture; Eyes Korean Market for eBook Cont...

Source: InvestorsHub NewsWire








GD ENTERTAINMENT & TECHNOLOGY, INC. (GDET) and WOWIO Announce Stock Swap and Joint Venture; Eyes Korean Market for eBook Content Distribution and English Language Learning



AGOURA, CA -- September 23, 2015 -- InvestorsHub NewsWire -- GD Entertainment & Technology, Inc. (OTC Markets: GDET), today announced that it has signed a definitive Joint Venture Agreement with WOWIO, Inc. (OTC Markets: WWIO) to join forces for the mutual development and exploitation of the WOWIO eBook platform in Korea and other Asian markets. In addition, GDET will seek to distribute WOWIO comic books and graphic novels in Korea in both print and digital form. The WOWIO platform allows for the insertion and tracking of targeted ads directly into the eBook, while providing a methodology for enhancing English language learning for the Korean market. A key part of this joint venture is a preferred stock swap between the two firms, signaling to the markets a deepened and long term commitment to their mutual growth and success.



We are excited about our relationship with GDET and believe that the two companies have tremendous synergies, said Brian Altounian, WOWIOs Chairman. We believe that shareholders from both our companies will benefit in the long term from our growing partnership.



The Korean market provides not only an untapped and growing market for the unique WOWIO platform, but also a way for WOWIO to distribute its proprietary intellectual properties, explained Dong Chung, CEO of GDET. In addition, our technology partners in Korea will enhance the patented WOWIO system to make it more mobile friendly and provide a way for Koreans to learn English in an engaging manner.



Lawrence Bracco, President/COO of GDET stated, The WOWIO platform and content provides us with a way to generate revenues in the first quarter of 2016. We plan on introducing the WOWIO comic/graphic novel library to the Korean market as a way to supplement their English learning in a way thats fun and engaging.



This joint venture with GDET, the first in a series of transactions we hope to accomplish in our new business plan, provides us with a very specific pathway to complete our technology platform, generate revenues and improve our balance sheet through the acquisition of GDET stock, said Robert Estareja, WOWIOs CEO, We are very pleased with the GDET team and vision, and look forward to deepening our relationship with them.



This joint venture also allows for the global cross-licensing of each others content and technology, and paves the way for the potential of an even broader relationship.



About GD Entertainment & Technology, Inc.:

GDET specializes in the development, production and exploitation of media and technologies worldwide. GDET and its management have created, produced, and/or distributed a variety of family-friendly content, including: Conan the Barbarian animated DVD, animated Voyages of Young Dr. Doolittle and Adventures of Odyssey and the acclaimed graphic novel series, The Almighty Bible, an ebook & print version of the Bible for teenagers. GDET principals have over 80 years of combined experience in producing and distributing media, consulting to and licensing major intellectual properties globally, including Warner Brothers, Marvel/Disney, and Mommy & Me. GDET has several projects in development including an animated feature film, a live stage show and an adaptation of a successful juvenile book series for digital video and mobile games. Its acclaimed graphic novel, The Son, is now being distributed in North America and Europe.



About WOWIO



WOWIO, Inc., (OTCBB: WWIO) is a digital media and technology development company with a patented process and a proprietary mobile ad-delivery platform that will disrupt the eBook distribution landscape by exploiting a previously untapped marketplace: ad-supported eBooks. Wowio has built and acquired a number of digital media technologies, platforms and distribution outlets and is focusing its efforts on opportunities to create and monetize ancillary content product lines beyond eBooks and other forms of digital media. To learn more about WOWIO, please visit our corporate website at http://www.studiowdigital.com.



Safe Harbor Statement



Information in this document constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "estimate," "project," "intend," "expect," "should," "believe," and similar expressions are intended to identify forward-looking statements. These statements involve, and are subject to known and unknown risks, which could cause GDET actual results, performance (financial or operating) or achievements to differ from the future results, performance or achievements expressed or implied by such forward-looking statements. The risks, uncertainties and other factors are more fully discussed in GDET filings and Disclosures. All forward-looking statements attributable to GDET herein are expressly qualified in their entirety by the above-mentioned cautionary statement. GD Entertainment & Technology, Inc. disclaims any obligation to update forward-looking statements contained herein, except as may be required by law.



Contact:

Lawrence Bracco

Tel: 805-208-3171 larrybracco@gdetinc.com

WWIO NEWS:

GD ENTERTAINMENT & TECHNOLOGY, INC. (GDET) and WOWIO Announce Stock Swap and Joint Venture; Eyes Korean Market for eBook Cont...

Source: InvestorsHub NewsWire








GD ENTERTAINMENT & TECHNOLOGY, INC. (GDET) and WOWIO Announce Stock Swap and Joint Venture; Eyes Korean Market for eBook Content Distribution and English Language Learning



AGOURA, CA -- September 23, 2015 -- InvestorsHub NewsWire -- GD Entertainment & Technology, Inc. (OTC Markets: GDET), today announced that it has signed a definitive Joint Venture Agreement with WOWIO, Inc. (OTC Markets: WWIO) to join forces for the mutual development and exploitation of the WOWIO eBook platform in Korea and other Asian markets. In addition, GDET will seek to distribute WOWIO comic books and graphic novels in Korea in both print and digital form. The WOWIO platform allows for the insertion and tracking of targeted ads directly into the eBook, while providing a methodology for enhancing English language learning for the Korean market. A key part of this joint venture is a preferred stock swap between the two firms, signaling to the markets a deepened and long term commitment to their mutual growth and success.



We are excited about our relationship with GDET and believe that the two companies have tremendous synergies, said Brian Altounian, WOWIOs Chairman. We believe that shareholders from both our companies will benefit in the long term from our growing partnership.



The Korean market provides not only an untapped and growing market for the unique WOWIO platform, but also a way for WOWIO to distribute its proprietary intellectual properties, explained Dong Chung, CEO of GDET. In addition, our technology partners in Korea will enhance the patented WOWIO system to make it more mobile friendly and provide a way for Koreans to learn English in an engaging manner.



Lawrence Bracco, President/COO of GDET stated, The WOWIO platform and content provides us with a way to generate revenues in the first quarter of 2016. We plan on introducing the WOWIO comic/graphic novel library to the Korean market as a way to supplement their English learning in a way thats fun and engaging.



This joint venture with GDET, the first in a series of transactions we hope to accomplish in our new business plan, provides us with a very specific pathway to complete our technology platform, generate revenues and improve our balance sheet through the acquisition of GDET stock, said Robert Estareja, WOWIOs CEO, We are very pleased with the GDET team and vision, and look forward to deepening our relationship with them.



This joint venture also allows for the global cross-licensing of each others content and technology, and paves the way for the potential of an even broader relationship.



About GD Entertainment & Technology, Inc.:

GDET specializes in the development, production and exploitation of media and technologies worldwide. GDET and its management have created, produced, and/or distributed a variety of family-friendly content, including: Conan the Barbarian animated DVD, animated Voyages of Young Dr. Doolittle and Adventures of Odyssey and the acclaimed graphic novel series, The Almighty Bible, an ebook & print version of the Bible for teenagers. GDET principals have over 80 years of combined experience in producing and distributing media, consulting to and licensing major intellectual properties globally, including Warner Brothers, Marvel/Disney, and Mommy & Me. GDET has several projects in development including an animated feature film, a live stage show and an adaptation of a successful juvenile book series for digital video and mobile games. Its acclaimed graphic novel, The Son, is now being distributed in North America and Europe.



About WOWIO



WOWIO, Inc., (OTCBB: WWIO) is a digital media and technology development company with a patented process and a proprietary mobile ad-delivery platform that will disrupt the eBook distribution landscape by exploiting a previously untapped marketplace: ad-supported eBooks. Wowio has built and acquired a number of digital media technologies, platforms and distribution outlets and is focusing its efforts on opportunities to create and monetize ancillary content product lines beyond eBooks and other forms of digital media. To learn more about WOWIO, please visit our corporate website at http://www.studiowdigital.com.



Safe Harbor Statement



Information in this document constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "estimate," "project," "intend," "expect," "should," "believe," and similar expressions are intended to identify forward-looking statements. These statements involve, and are subject to known and unknown risks, which could cause GDET actual results, performance (financial or operating) or achievements to differ from the future results, performance or achievements expressed or implied by such forward-looking statements. The risks, uncertainties and other factors are more fully discussed in GDET filings and Disclosures. All forward-looking statements attributable to GDET herein are expressly qualified in their entirety by the above-mentioned cautionary statement. GD Entertainment & Technology, Inc. disclaims any obligation to update forward-looking statements contained herein, except as may be required by law.



Contact:

Lawrence Bracco

Tel: 805-208-3171 larrybracco@gdetinc.com

GD ENTERTAINMENT & TECHNOLOGY, INC. (GDET) and WOWIO Announce Stock Swap and Joint Venture; Eyes Korean Market for eBook Cont...

Source: InvestorsHub NewsWire








GD ENTERTAINMENT & TECHNOLOGY, INC. (GDET) and WOWIO Announce Stock Swap and Joint Venture; Eyes Korean Market for eBook Content Distribution and English Language Learning



AGOURA, CA -- September 23, 2015 -- InvestorsHub NewsWire -- GD Entertainment & Technology, Inc. (OTC Markets: GDET), today announced that it has signed a definitive Joint Venture Agreement with WOWIO, Inc. (OTC Markets: WWIO) to join forces for the mutual development and exploitation of the WOWIO eBook platform in Korea and other Asian markets. In addition, GDET will seek to distribute WOWIO comic books and graphic novels in Korea in both print and digital form. The WOWIO platform allows for the insertion and tracking of targeted ads directly into the eBook, while providing a methodology for enhancing English language learning for the Korean market. A key part of this joint venture is a preferred stock swap between the two firms, signaling to the markets a deepened and long term commitment to their mutual growth and success.



We are excited about our relationship with GDET and believe that the two companies have tremendous synergies, said Brian Altounian, WOWIOs Chairman. We believe that shareholders from both our companies will benefit in the long term from our growing partnership.



The Korean market provides not only an untapped and growing market for the unique WOWIO platform, but also a way for WOWIO to distribute its proprietary intellectual properties, explained Dong Chung, CEO of GDET. In addition, our technology partners in Korea will enhance the patented WOWIO system to make it more mobile friendly and provide a way for Koreans to learn English in an engaging manner.



Lawrence Bracco, President/COO of GDET stated, The WOWIO platform and content provides us with a way to generate revenues in the first quarter of 2016. We plan on introducing the WOWIO comic/graphic novel library to the Korean market as a way to supplement their English learning in a way thats fun and engaging.



This joint venture with GDET, the first in a series of transactions we hope to accomplish in our new business plan, provides us with a very specific pathway to complete our technology platform, generate revenues and improve our balance sheet through the acquisition of GDET stock, said Robert Estareja, WOWIOs CEO, We are very pleased with the GDET team and vision, and look forward to deepening our relationship with them.



This joint venture also allows for the global cross-licensing of each others content and technology, and paves the way for the potential of an even broader relationship.



About GD Entertainment & Technology, Inc.:

GDET specializes in the development, production and exploitation of media and technologies worldwide. GDET and its management have created, produced, and/or distributed a variety of family-friendly content, including: Conan the Barbarian animated DVD, animated Voyages of Young Dr. Doolittle and Adventures of Odyssey and the acclaimed graphic novel series, The Almighty Bible, an ebook & print version of the Bible for teenagers. GDET principals have over 80 years of combined experience in producing and distributing media, consulting to and licensing major intellectual properties globally, including Warner Brothers, Marvel/Disney, and Mommy & Me. GDET has several projects in development including an animated feature film, a live stage show and an adaptation of a successful juvenile book series for digital video and mobile games. Its acclaimed graphic novel, The Son, is now being distributed in North America and Europe.



About WOWIO



WOWIO, Inc., (OTCBB: WWIO) is a digital media and technology development company with a patented process and a proprietary mobile ad-delivery platform that will disrupt the eBook distribution landscape by exploiting a previously untapped marketplace: ad-supported eBooks. Wowio has built and acquired a number of digital media technologies, platforms and distribution outlets and is focusing its efforts on opportunities to create and monetize ancillary content product lines beyond eBooks and other forms of digital media. To learn more about WOWIO, please visit our corporate website at http://www.studiowdigital.com.



Safe Harbor Statement



Information in this document constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "estimate," "project," "intend," "expect," "should," "believe," and similar expressions are intended to identify forward-looking statements. These statements involve, and are subject to known and unknown risks, which could cause GDET actual results, performance (financial or operating) or achievements to differ from the future results, performance or achievements expressed or implied by such forward-looking statements. The risks, uncertainties and other factors are more fully discussed in GDET filings and Disclosures. All forward-looking statements attributable to GDET herein are expressly qualified in their entirety by the above-mentioned cautionary statement. GD Entertainment & Technology, Inc. disclaims any obligation to update forward-looking statements contained herein, except as may be required by law.



Contact:

Lawrence Bracco

Tel: 805-208-3171 larrybracco@gdetinc.com

So, Curt Kramer is a majority stock holder. I hope he's learned his lesson and keep hands out of Wowio business.

Then take one for the team.

Hahaha... Brunch.

He can buy mine for .005

Show proof! Waiting for news!

How about increasing my stock value beyond .0001!!

Haha... And everyone thought the price would never change.

BRNE: getting some major attention.
Read and decide for yourself.

http://www.octafinance.com/iconic-holdings-just-bought-borneo-resource-investments-ltd-stake/

BRNE: getting some major attention.
Read and decide for yourself.

http://www.octafinance.com/iconic-holdings-just-bought-borneo-resource-investments-ltd-stake/

BRNE: getting some major attention.
Read and decide for yourself.

http://www.octafinance.com/iconic-holdings-just-bought-borneo-resource-investments-ltd-stake/

Just couldn't stay away could you. What is the obsession with slamming this stock? You are trying to purposely hurt the financial wellbeing of the stockholders with your poppycock! You know nothing more than anyone else here. I wish the SEC would do something about people like you.